These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8355916

  • 1. 99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.
    Rubini G, Lauriero F, Rubini D, D'Addabbo A.
    Nucl Med Commun; 1993 Jul; 14(7):567-72. PubMed ID: 8355916
    [Abstract] [Full Text] [Related]

  • 2. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A, Dicembrino F, Chiodini I, Minisola S, Fusilli S, Di Giorgio A, Garrubba M, D'Aloiso L, Frusciante V, Torlontano M, Modoni S, Trischitta V, Trischitta V, Carnevale V.
    Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
    [Abstract] [Full Text] [Related]

  • 3. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
    D'Addabbo A, Rubini G, Mele M, Lauriero F.
    Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
    [Abstract] [Full Text] [Related]

  • 4. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L, Peris P, Pons F, Guañabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Martínez de Osaba MJ, Muñoz-Gómez J, Ballesta AM.
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [Abstract] [Full Text] [Related]

  • 5. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F, Alvarez L, Peris P, Guañabens N, Vidal-Sicart S, Monegal A, Pavía J, Ballesta AM, Muños-Gómez J, Herranz R.
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [Abstract] [Full Text] [Related]

  • 6. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
    Smith ML, Fogelman I, Ralston S, Boyce BF, Boyle IT.
    Metab Bone Dis Relat Res; 1984 Jun; 5(4):167-70. PubMed ID: 6429474
    [Abstract] [Full Text] [Related]

  • 7. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents.
    Bushnell DL, Madsen M, Kahn D, Nathan M, Williams RD.
    Nucl Med Commun; 1999 Oct; 20(10):875-81. PubMed ID: 10528290
    [Abstract] [Full Text] [Related]

  • 8. Atypical Paget's disease with quantitative assessment of tracer kinetics.
    Gnanasegaran G, Moore AE, Blake GM, Vijayanathan S, Clarke SE, Fogelman I.
    Clin Nucl Med; 2007 Oct; 32(10):765-9. PubMed ID: 17885354
    [Abstract] [Full Text] [Related]

  • 9. The diphosphonate space: a useful quantitative index of disease activity in patients undergoing hydroxy methylene diphosphonate (HMDP) bone imaging for Paget's disease [corrected].
    Evans A, Perkins A, Wastie M, Stone M, Hosking D.
    Eur J Nucl Med; 1991 Oct; 18(9):757-9. PubMed ID: 1809266
    [Abstract] [Full Text] [Related]

  • 10. Polyostotic Paget's disease.
    Butt ST, Fatima S, Butt R, Nasir W, Jameel G, Irfan J.
    J Coll Physicians Surg Pak; 2012 Jul; 22(7):461-3. PubMed ID: 22747870
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP, Edwards S, Lazarus CR, Malamitsi J, Maisey MN, Mashiter GD, Winn PJ.
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
    Bonnin MR, Moragues C, Nolla JM, Lirón FJ, Roig-Escofet D, Navarro MA.
    Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
    [Abstract] [Full Text] [Related]

  • 19. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR.
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [Abstract] [Full Text] [Related]

  • 20. Evaluation by using radionuclide uptake of bone in Paget's disease of bone: special reference to treatment with calcitonin.
    Dokoh S, Fukunaga M, Yamamoto I, Torizuka K, Morita R.
    Radioisotopes; 1988 Jun; 37(6):339-42. PubMed ID: 3212230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.